An international consortium of researchers has pinpointed a specific region within the human brain directly implicated in elevated blood pressure readings. This area is known as the lateral parabrachial nucleus—a largely uncharted section of the brain previously understood primarily for its role in respiration control. Nonetheless, contemporary trials demonstrate that its functional scope is significantly broader.
Experiments conducted on rodents revealed that the neurons residing in this locus possess the capability not only to regulate breathing but also to induce vasoconstriction, which subsequently results in a rise in systemic pressure. It was determined that this cerebral domain establishes connections with the sympathetic nervous system—the very system responsible for initiating the body’s response to stressors and threats. Excessive sympathetic nervous system activity correlates with persistently high blood pressure levels in individuals. “We observed that this region becomes more active when pressure is elevated, and deactivating it results in pressure returning to normal,” stated physiologist Julian Paton from the University of Auckland (New Zealand).
This breakthrough offers an explanation for why some individuals suffering from hypertension fail to experience pressure reduction even with consistent medication schedules. Research suggests that nearly half of all hypertension cases possess a neurogenic origin, meaning the underlying cause lies within the nervous system’s functioning rather than issues with the vasculature or renal system. Furthermore, investigators established a link between sleep apnea and elevated blood pressure: when the brain experiences oxygen deprivation or experiences a buildup of surplus carbon dioxide, the neurons in this specific area become stimulated.
Direct intervention within the brain tissue is, naturally, too hazardous. Consequently, the scientists propose targeting the carotid bodies—minute chemoreceptors situated in the neck where the carotid artery bifurcates. Regulating activity in these receptors presents a pathway to diminish the overactivity of the implicated brain zone. The findings of this investigation were formally published in the journal Circulation Research.
Currently, all trials remain confined to animal models, but the initial outcomes are already garnering considerable acclaim from experts. Should subsequent studies corroborate the efficacy of this proposed method, it could pave the way for entirely novel approaches to managing hypertension in the future—approaches that do not necessitate daily pill consumption.
About the Author
